Industries > Pharma > Global Inhalation Anaesthesia Market Report 2019-2029

Global Inhalation Anaesthesia Market Report 2019-2029

Analysis by Product Type (Sevoflurane, Desflurane, Isoflurane), Application (Induction, Maintenance), Plus Company and Country Analysis and Forecasts

PAGES: 149

WOOCS 2.2.1
SKU: PHA0432 Categories: , Tag:

Market Definition:
• Inhalational anesthesia (IA) become the anesthetic of choice over Intravenous Anesthesia (IVA) among majority of healthcare practitioners, as it helps avoid excessive dosage and keeps the patient’s autonomic functions intact. IA has lower risk of delirium and is cost effective compared to IVA
• Inhalational anesthesia used for sedation as well as for the induction and maintenance of general anesthesia. The most common inhalational anesthetics are sevoflurane, desflurane, and nitrous oxide.

Market Overview and Trends
• To address the environmental impact of anesthetic gases, new technologies are being developed to scavenge them from hospital vents and recycle them.
• These anesthetic gases contribute up to 1.0% of global carbon dioxide emissions, leading to greater environmental damage.
• The major concern in using anesthetic gases is that patient use accounts for only 5.0% and the rest 95.0% is released into the atmosphere which contributes to global warming

Market Dynamics:

Factors Influencing the Market Growth:
• Rapid rise in aging population suffering from cancer, cardiovascular, spinal, orthopedic, respiratory, gastrointestinal, neurological, and other diseases and disorders is anticipated to drive the growth
• Increasing number of emergency cases and accidents are also expected to positively influence market growth
• Increasing number of orthopedic procedures such as ligament and other soft tissue repair procedures is also contributing to growth of the day care ambulatory surgeries, which is expected to boost usage of inhalation anesthesia.

Factors Restraining the Market Growth:
• Inhalational anesthetics cause respiratory depression, a decrease in arterial blood pressure and cerebral metabolic demand, and an increase in cerebral blood flow that may hinder the growth of the market.

Market Segmentation 2019-2029:
The inhalation anesthesia market is segmented on the product type, application, and geography.

Product Type
• Sevoflurane Market, 2019-2029
• Desflurane Market, 2019-2029
• Isoflurane Market, 2019-2029

• Induction Market, 2019-2029
• Maintenance Market, 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the inhalation anesthesia market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.
• Baxter Healthcare is the only player with all the 3 products in its portfolio. AbbVie Inc. has sevoflurane and isoflurane in its portfolio. Piramal Healthcare presently has sevoflurane and isoflurane in its portfolio and may capture a significant market share of Baxter in the years to come owing to new product launches

Major Market Players:
Halocarbon Products Corporation; Hikima Pharmaceuticals PLC; Lunan Pharmaceutical Group Co. Ltd.; Piramal Enterprises Limited; Jiangsu Hengrui Medicine Co. Ltd.; Fresenius Kabi AG, and AbbVie Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Global Inhalation Anaesthesia Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Global Inhalation Anaesthesia Market Report 2019-2029

Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019


“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019


“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019


“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019